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It is frequently difficult to find an optimal nutritional treatment for children who have rare 
genetic conditions with multisystem abnormalities because of the complexity of symptoms and the lack 
of evidence based treatments. Bardet-Biedl Syndrome is an example of one of these conditions. Bardet-
Biedl Syndrome (BBS) is a rare autosomal recessive condition that is characterized by polydactyly, rod-
cone dystrophy, obesity, and developmental delay (Forsythe & Beales, 2013). Obesity is a significant 
obstacle for medical professionals when working with these patients. Patients with Bardet-Biedl 
Syndrome have lower energy expenditure and leptin sensitivity causing them to have rapid weight gain 
even with caloric restrictions (Rahmouni et al., 2008). Obesity and other clinical manifestations 
suggestive of Bardet-Biedl Syndrome were observed with one patient at an area hospital, and the 
registered dietitian was called upon to determine how best to manage her nutrition. 
 The patient is a 20 month female who was born at 37 weeks gestations weighing four pounds 
ten ounces. Her mother and father were ages 33 and 37, respectively, Indian, and first cousins. A 
microarray conducted of the patient’s parents showed large segments of homozygosity. The patient’s 
father is a computer engineer and her mother is a registered dietitian. The patient currently lives with 
her parents, grandparents, and one male sibling, who was diagnosed with familial adenomatous 
polyposis. The patient’s extended family’s medical history includes hemochromatosis, gastroesophageal 
reflux hypothyroidism, hypertension, diabetes, hyperlipidemia, polydactyly, ventricular septal defect, 
and stroke. 
 The patient’s mother’s pregnancy was complicated by hypertension, pre-eclampsia, carpal 
tunnel syndrome, headache and proteinurea. The patient was in the NICU treated with Cpap for the first 
two days of life because of work of breathing and temperature instability. The patient was discharged 
then readmitted two days later for hypothermia. Although the patient was initial fed fortified breast 
milk via bottle for the first two to three days of life, she transitioned to only breast milk when she began 
gaining weight too rapidly.  
The patient was born with features that suggested possible Bardet-Biedl syndrome. These 
features included polydactyly, renal echogenicity, and gastrointestinal reflux. She also began to rapidly 
gain weight several weeks after birth, which is another feature of Bardet-Biedl Syndrome. The patient 
was not diagnosed with Bardet- Biedl Syndrome three months after birth because she did not exhibit all 
the necessary criteria; she lacked retinitis pigmentosa.  To confirm the syndrome, the patient was 
enrolled in the NC Genes Research Study which uses whole exome sequencing. NC Gene Research Study 
found a mutation predicted to be pathogenic in one of the reported genes for Bardet-Biedl Syndrome. 
Clinical findings were consistent with a diagnosis of BBS10. The BBS10 mutation is associated with 
earlier occurrence and more severe form of vision problems than other BBS mutations. To test the 
results from the NC Genes Research Study, the Molecular Genetics Laboratory at University of North 
Carolina at Chapel Hill Hospital (UNCH) performed Sanger DNA sequencing analysis which showed that 
the patient was homozygous for a BBS10 variant (BBS10 H395R) which changes histidine to an arginine 
in the chaperone protein C12ORF58. 
 Throughout her life, the patient has had a complex medical history. She was diagnosed with a 
benign heart murmur at the age of five months which was set to be re-evaluated if still present at the 
age of three years old. The patient also had ongoing constipation which was managed with prunes and 
Miralax.  As the patient’s fluid intake decreased, however, the patient constipation worsened despite 
the Miralax and treatment is still ongoing for her constipation. 
 Along with constipation, the patient also saw a gastrointestinal specialist for feeding difficulties. 
The patient would gag on solids and liquids. The patient had reflux symptoms from one month of age 
with wet burps and coughing. She underwent two modified barium swallow studies which showed mild-
moderate oro-pharyngeal dysphagia with deep laryngeal penetration with thin liquids. A Speech and 
Language Pathologist recommended slightly thickened liquids and purees to avoid aspiration. The 
patient was treated with multiple medications including rantidine, omeprazole, and erthyromycin. 
 At the age of one month of age, a renal ultra sound found echogenic kidneys with possible 
tubular ectasia. At thirteen months, a MRI of abdomen and pelvis found a conglomeration of lymph 
nodes anterior to the right kidney with prominent bilateral inguinal, iliac chain, and retroperitoneal 
lymph nodes. At fifteen months, patient was found to have right SFU (Society of Fetal Ultrasound) grade 
2 hydronephrosis, intermittent left SFU grade 1 hydronephrosis, and abnormal increased echogenicity of 
the medullary pyramids.  
 The patient‘s milestones were initially normal.  She smiled at thirteen weeks. She rolled 
from stomach to back and sat up at 6 months. By ten months the patient was pulling herself up and 
standing for a few minutes. She also began to babble and say three words. After one year of age, 
however, the patient began to rapidly lose her milestones. She refused to bear weight and could not 
hold her head up when sitting. She had episodes of loss of tone where her head and body would drop to 
the right side or she was thrown backwards. The patient also began to experience drop attacks and 
disconjugated eye movements. Although ataxia is common in Bardet-Biedl Syndrome, motor decline is 
concerning for Opsoclonus Myoclonus Syndrome. A brain MRI showed hypoplasia of the CNS and 
atrophy of the corpus callosum with associated hippocampal malrotation. At thirteen months, lab 
studies showed an increase in B-cells, which could identify an immune system disorder that caused her 
motor skills regression. The patient was treated with IV immunoglobulin G (IVIG) and steroids in order to 
suppress her immune system to see if her symptoms improved. The symptoms including head 
movements and eye movements improved after IVIG infusion and high dose dexamethasone, but the 
patient still refused to bear weight on her feet and would fall back when sitting up. The patient was 
diagnosed with Opsoclonus Myoclonus Syndrome (OMS). The patient’s symptoms returned several 
weeks after treatment and she was given Rituximab infusion. She initially showed improvements with 
treatment but after several weeks her symptoms returned. She was given two more Rituximab infusions 
and Ofatumumab. Rituximab and Ofatumumab are anti CD20 IgG1k human monoclonal antibodies that 
were given in attempt to suppress her immune system and improve her symptoms. At 19 months of age 
the patient began to have insomnia and rage attacks which are common in OMS.  The patient would 
wake up angry and would not calm down unless given formula. The patient was prescribed trazadone, 
melatonin, and clonidine to improve sleep and behavior. The patient was also referred to a multiple 
disciplinary teams at an outside hospital for management of symptoms.  
Patient had an Electroretinography at fifteen months of age which showed abnormalities 
consistent with retinitis pigmentosa. The patient was prescribed glasses for myopia. Her 
ophthalmologist did not believe that her disconjugated eye movements were related to 
ocular/retinal/myopia issues.   
Throughout her life, the patient’s mom reported that the patient had chronic colds with noisy 
breathing while eating and sleeping. She also had stertor and intermittent stridor. The patient was 
hospitalized multiple times for wheezing, fevers, and respiratory infections. She had two bronchoscopy 
procedures. The bronchoscopy performed at 10 months found moderate tracheomalacia with apparent 
outpouching in posterior membrane of trachea, mild adenoidal hypertrophy, a bifid uvula, and 
bronchitis. The second bronchoscopy showed various levels of upper airway narrowing but little 
adenoidal tissue. She was treated with Pulmicort for reactive airway disease and Flonase to reduce 
adenoid size and improve airway patency. Her increased vomiting also negatively impacted her 
pulmonary function. The pulmonary team is still trying to find an effective treatment plan for her. 
 The patient was initially followed by a dietitian to evaluate growth and oral intake. During the 
first months of life, she began gaining weight rapidly. Her weight gain velocity was twice as rapid as 
children her age without Bardet-Biedl Syndrome. She also had reflux symptoms including wet burps and 
vomiting. She was seen by the area hospital dietitian at seventeen months. Her intake at that time 
consisted of 16-20 ounces of Enfagrow Gentlease, a partially hydrolyzed infant formula that is easier for 
infants to digest than standard formula. She also ate three meals per day that were diverse and 
meticulously portioned by her mother who is a registered dietitian.  The patient was eating 600-900 
kcal/day which is 52 kcal/kg.  52 kcal per kg is significantly lower than the DRI for her age which is 82 
kcal/kg (Bunting et al., 2013).  
Patient was experiencing reflux symptoms and constipation which were being addressed by 
Gastroenterology. Her formula was changed to Nutramigen Toddler, a hydrolyzed formula and then to 
Neocate Infant, an elemental formula and the volume of formula was decreased in attempt to address 
her GI symptoms and reduce her weight gain. The dietitian also recommended an increase in daily fluids 
to help constipation and ensure adequate fluid intake. Despite these changes to her formula, the patient 
continued to gain weight rapidly. Since the patient was also constipated and vomited whenever she 
drank water her formula recipe was changed to reduce calories and 8 ounces of water was mixed into 
her pureed foods to add fluids. 
During my visit, I observed the patient and worked with her mother to create a nutrition plan 
that would best suit the patient’s needs. At first glance, the patient looked older than 20 months. She 
was larger in size and taller than most children her age. She was unable to hold her weight up when she 
sat and her mother had to hold her head. The mother had difficulty holding her due to her size and 
struggled when the patient’s diaper needed to be changed.  
 The mother had met with the pediatric registered dietitian several times before this visit and 
told me the various changes that they had made. The mother was very frustrated at the fact that despite 
the changes in formula type, volume, and recipe, the patient continued to gain weight quickly and her GI 
symptoms had not improved. The patient was also still vomiting when drinking water. Due to her emesis 
and reduced formula volume, there was a concern for inadequate fluid intake and dehydration. The RD 
had recommended adding an additional eight ounces of water mixed into her pureed foods each meal.  
A daily liquid multivitamin was also indicated because it was unclear the amount of nutrients from 
formula and foods she was able to absorb due to her emesis and the reduction in formula. While her 
formula recipe and volume were not changed at this visit, the mom and RD discussed working with a RD 
that specializes in Bardet-Biedl syndrome and possibly trying a Ketogenic or modified Atkins diet to 
reduce weight gain.  
The patient discussed was diagnosed with Bardet-Biedl Syndrome. Bardet Biedl Syndrome (BBS) 
is a rare pleiotropic genetic disorder characterized by clinical features such as polydactyly and retinal 
pigmentosa (Forsythe & Beales, 2013). Although genetic testing can be performed early in life, the 
Bardet-Biedl Syndrome phenotype can change over time. Most individuals who are suspected to have 
BBS are diagnosed during adolescence or early adulthood. Some clinical features can be observed at 
birth such as polydactyly; others such as rod-cone dystrophy usually arise within the first ten years of 
life. Other clinical features of Bardet-Biedl Syndrome include obesity, genital and renal anomalies, 
learning difficulties, and developmental delay (Forsythe & Beales, 2013). To be diagnosed with Bardet-
Biedl Syndrome, the patient must exhibit four of the primary features of BBS or three primary features 
and two secondary features (Forsythe & Beales, 2013). The primary and secondary features of Bardet-
Biedl Syndrome are found in Table 1.  
Gene sequencing can be used to confirm the diagnosis of Bardet-Biedl and has 80% success. The 
prevalence of Bardet-Biedl syndrome differs among different locations. The prevalence of BBS is 
1:160,000 in Northern European countries (Forsythe & Beales, 2013). Higher prevalence has been found 
in areas such as Kuwait and Newfoundland. The prevalence of Bardet-Biedl syndrome in Kuwait is 
1:13,500 (Forsythe & Beales, 2013) and 1:18,000 (Fan et al., 2004). A possible reason for the increased 
prevalence in these areas is the increased amount of consanguinity that exists (Forsythe & Beales, 
2013). 
Bardet-Biedl Syndrome is typically inherited in an autosomal recessive pattern but a few 
individuals have inherited the syndrome in a triallelic manner (Fan et al., 2004). Sixteen Bardet-Biedl 
genes have been identified (Forsythe & Beales, 2013). Although there are regional difference of 
prevalence of mutations, the most common mutations are BBS1 (23%) and BBS10 (20%) (Forsythe and 
Beales, 2013).  BBS1 mutations have been linked to a specific region in Newfoundland. The mutation has 
been identified as a missense mutation in which T was replaced with a G in exon 12. This mutation 
results in a homozygous state and causes expression of a different amino acid (M390R) (Fan et al., 
2004). BBS1 mutation and other mutations common to BBS have been shown to affect cilia function and 
maintenance, leptin receptors, and POMC neurons. 
Table 1 Diagnostic features and prevalence in BBS 
Features Frequency 
Primary features  
Rod-cone dystrophy 93% 
Polydactyly 63–81% 
All four limbs: 21% 
Upper limbs only: 9% 
Lower limbs only:21% 
Obesity 72–92% 
Genital anomalies 59–98% 
Renal anomalies 53% 
Learning difﬁculties 61% 
Secondary features  
Speech delay 54–81% 
Developmental delay 50–91% 
Diabetes mellitus 6–48% 
Dental anomalies 51% 
Congenital heart disease 7% 
Brachydactyly/ syndactyly 46–100%/8–95% 
Ataxia/ poor coordination 40–86% 
Anosmia/hyposmia 60% 
(Forsythe and Beales, 2013) 
Bardet-Biedl Syndrome is a rare disease with ongoing research being conducted in order to gain 
more information about the nature of the disease and the most optimal treatment procedures for 
patients. Obesity is a huge concern for BBS patient such as the patient described above. One reason for 
obesity is as result of the Bardet Biedl Syndrome the patient may have decreased energy expenditure. 
While the DRI for her age is appropriate for sedentary children, the patient may have an even lower 
energy expenditure than sedentary children. The mother reported the patient had low activity level, she 
would crawl infrequently and spent most time lying down. The patient slept four to five hours per night 
due to insomnia. In a study with BBS knockout mice, Rahmouni et al. (2008) found that given the same 
amount of food for 13 weeks, BBS mice had 2-3 times higher fat deposits then wild type mice. The study 
suggests “these results indicated that BBS mice have low energy expenditure, which may contribute to 
obesity in these animals” (Rahmouni et al., 2008). 
Another component of Bardet-Biedl Syndrome is the effect on cilia and satiety signaling. Cilia 
are organelles located on exterior of cells that are responsible for cellular motility and signaling. In 
Bardet-Biedl Syndrome, normal cilia function is disrupted which can cause kidney disease, retinal 
degeneration, and obesity (Gupta, Prodromou, & Chapple, 2009). “One emerging and important  
mechanism to achieve weight control in mammals is the involvement of primary cilia, which presumably 
transduce satiety signals via appetite-modulating  receptors, such as the leptin receptor, Sstr3, and 
Mchr1 as well as other signaling molecules including AC3 (Heydet et al., 2012). The loss of CNS cilia, 
especially POMC expressing neurons of the hypothalamus which are involved in energy homeostasis, 
results in hyperphagia. This hyperphagia causes the animals to become obese and develop metabolic 
syndrome complications. Hypothalamic cilia have been shown to be associated with the management of 
satiety (Heydet et al., 2012).   
The cilia dysfunction is suggested to be affecting leptin receptor signaling (Gupta, Prodromou, & 
Chapple, 2009). One study of BBS knockout mice showed that despite similar treatment, BBS knockout 
mice had increased levels of plasma leptin and higher level of leptin resistance than wild type mice. 
Leptin is a peptide hormone secreted by the adipose tissue that is responsible in modulating energy 
homeostasis. If an individual has leptin resistance, they do not have satiety cues and will consume more 
food than they need.  
The Bardet-Biedl Syndrome patient exhibits the hyperphagia that is common to Bardet-Biedl 
Syndrome. At home, the mother reported that the patient constantly wanted to eat and would be 
become angry when she was denied food. The patient would wake up during the night screaming for 
food and would not go back to sleep unless she was fed. The mother tried to give the patient water 
during the night to calm her down but it would not satisfy her and she would continue to cry. In attempt 
to decrease the calories that the patient was ingesting, the mother would give the patient watered 
down formula at night. The mother was also cutting the patient’s food in very small pieces so that the 
meal will last longer. Throughout the visit the patient was extremely fussy, using sign language to sign 
“more” to indicate that she wanted more food. When she was not given more food she began to scream 
and violently move her extremities. When her mother gave her a bottle of formula, she drank it at a 
rapid speed and then signed “more” again.  After the feeding, the patient showed signs of reflux with 
wet burps and small amounts of spit up. The mother discussed her frustrated at her daughters eating 
habits. While the mother tries to portion the patient’s meals, she also feels guilty and upset when she 
cries that she is hungry. The patient becomes angrier if she is not fed and will scream uncontrollably.  
Currently, there are no official nutrition DRIs for Bardet-Biedl syndrome. The lack of appropriate 
DRIs for this syndrome makes it difficult for nutrition professionals to provide accurate nutrition 
recommendations. Recently, the mother went to a Bardet-Biedl Syndrome conference and will be 
working with a registered dietitian that specializes in Bardet-Biedl Syndrome.  A BBS specialist will be 
able to provide more appropriate nutrition recommendations for patients with Bardet-Biedl Syndrome 
as well as address the emotional stress of hyperphagia. Hopefully as more information emerges on BBS 
and effective treatment methods, more registered dietitians will be trained to treat Bardet-Biedl 
Syndrome patients 
Bardet-Biedl Syndrome is a rare autosomal recessive genetic disorder that presents with 
multiple physical findings, including polydactyly and obesity. The patient observed was diagnosed with 
Bardet-Biedl Syndrome and exhibited many of the clinical features that are consistent with the 
syndrome. Since BBS is rare, studies are still ongoing to discover the mechanism of the disease and 
identify the best treatment options for patients with Bardet-Biedl Syndrome. Future research is 
indicated to provide nutrition professionals the information needed to effectively treat the various 
problems associated with Bardet-Biedl Syndrome, especially hyperphagia.  
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